Avadel Pharmaceuticals – New Data On Narcolepsy Treatment
Jennifer Gudeman, Vice President, Medical and Clinical Affairs at Avadel Pharmaceuticals discusses new clinical data from the pivotal phase 3 REST-ON cl...
76 articles
Jennifer Gudeman, Vice President, Medical and Clinical Affairs at Avadel Pharmaceuticals discusses new clinical data from the pivotal phase 3 REST-ON cl...
Hong Tang, Chief Medical Officer at OnQuality Pharmaceuticals, a clinical stage pharma company pioneering the discovery and development of targeted canc...
Richard Marsden, CEO of Synairgen plc discusses full results from its SGO16 Phase II trial of its inhaled interferon beta formulation (SNG001) for the t...
Opioid use and dependency increased during the pandemic. Learn more on Health Professional Radio.
Returned guest, Bruce Boise, author of the book "Cold Comfort: One Man's Struggle to Stop the Illegal Marketing of Powerful Opioid Drugs and Save Lives"...
Scott Megaffin, CEO of Adastra Pharmaceuticals, Inc., a company focused on the treatment of cancers with high unmet needs (such as high-grade gliomas), ...
Robert Davidson, CEO of CURE Pharmaceutical, a drug delivery and development company discusses their delivery platform called CUREform™, which include...
Diane Newman, urologic nurse practitioner from the University of Pennsylvania Penn Center for Continence and Pelvic Health, Division of Urology discusse...
Pharmacologist and President of The People's Pharmacy, Joe Graedon, discusses Authorized Generics, what they are and the difference between Authorized G...
Spiro Rombotis, President and CEO of Cyclacel Pharmaceuticals, a developer of novel therapies that target various phases of cell cycle control for the t...